PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models

Authors

Institutions

Publication Details

Journal
Journal of Experimental & Clinical Cancer Research
Published
2026-01-08
DOI
https://doi.org/10.1186/s13046-025-03635-w
Citations
1
Primary Topic
Protein Degradation and Inhibitors
Type
article
Field-Weighted Citation Impact
22.24
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models

Luigi Fattore, Elisa Melucci, Fabio Pelle, Claudio Botti et al.
1 citations
Journal of Experimental & Clinical Cancer Research
Protein Degradation and Inhibitors
22.24
article

PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models

Luigi Fattore, Elisa Melucci, Fabio Pelle, Claudio Botti, Rita Mancini, Marta Di Martile, Marica Di Caprio, Elisabetta Valentini, Simona D’Aguanno, Donatella Del Bufalo, Matteo Brignone, Arianna Ortolano, Dante Rotili, Adriana Maria Di Stefano, Giulia Gentile, Gennaro Ciliberto
article en
1 citations

Abstract

No abstract available for this paper.
Journal of Experimental & Clinical Cancer ResearchVol. 45(1)
University of Siena (IT), Roma Tre University (IT), Azienda Ospedaliera Sant'Andrea (IT), Unitelma Sapienza University (IT), National Cancer Institute (MY), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Link Campus University (IT), Sapienza University of Rome (IT)
Good health and well-being
Openalex Percentile: Top 3%
Protein Degradation and Inhibitors
22.24
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models — Luigi Fattore, Elisa Melucci, et al. · Journal of Experimental & Clinical Cancer Research (2026) | TGRS Research Map | TGRS